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Key Points
• A systematic literature review identified nine CER methods guidance documents.
• These documents present more than three hundred individual methods recommendations, covering topics such as study design, bias, and statistical analysis.
• Categories of shared methods recommendations were assembled which embodies a consensus of recommendations for CER methods.
• All nine documents recommended transparency and adaptation for relevant stakeholders in the interpretation and dissemination of results.
• Other shared recommendations identified in at least seven documents included transparent operational definitions allowing for replication, assessment of data and study measure validity, inclusion of clinically meaningful and objectively measured outcomes, and focusing on gap in knowledge that are relevant for decision-makers.
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Introduction
As a result of an ever-increasing number of treatment options, real-world evidence is needed to inform clinical decision-making. Consequently, the demand for high-quality comparative effectiveness research (CER) has increased over the past several years. The Institute of Medicine has defined CER as, "the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of While CER is a newer term to describe an existing discipline that has carried various names, the focus of our search for methods guidelines was specific to this term that was popularized by the American Reinvestment and Recovery Act.
A search result title was assessed for relevance to CER methods by the inclusion of specific words, including "methods," "methodology," "standards," "conducting,"
"guidelines," and "practices". Subsequently, the abstracts from the results with relevant titles were reviewed. The following information was collected from each abstract:
author(s), year of publication, and affiliations. Each abstract was categorized as a CER overview, a presentation of specific analytic methods, or a study of a specific therapeutic topic. Only full-text documents categorized as a CER overview were obtained and analyzed for potential inclusion as a CER methods guidance document. Any document not consisting of a set of formal recommendations on CER methods, or those related to meta-analyses or systematic reviews, were excluded. Guidance documents released as part of a series or an update were included together as a single guide. Documents published through December 2014 were included in our review.
All recommendations regarding CER methods were extracted from each guidance document by two independent reviewers (JM, RM). The content of each statement was assessed to determine whether the statement provided guidance for conducting CER, and therefore should be considered a CER recommendation.
Statements not meeting this criterion were excluded. The list of included recommendations were agreed upon by both reviewers and an additional author (AC).
Results
We reviewed Only one shared recommendation category was identified across all nine CER documents, suggesting that the interpretation and dissemination of CER study results should be transparent and adapted for relevant stakeholders (Table 2 ). Other frequently shared CER methods recommendations included: study design and operational definitions developed a priori and transparent enough to allow for replication (n=8 documents, 89%); focus on areas with gaps in current clinical knowledge that are relevant to decision-makers (n=7, 78%); assess and discuss validity of measures, instruments, and data, including data collection (n=7, 78%); outcomes, including benefits and harms, should be clinically meaningful, and objectively measured (n=7, 78%);
appropriateness of exposures and interventions should be assessed and described (n=6, 67%).
Assessment for and strategies to minimize bias (n=6 documents), confounding (n=6), and heterogeneity (n=4) were also commonly shared recommendations between documents. Other shared recommendations supported rigorous literature review to guide study design and planning (n=6, 67%), use of sensitivity analyses (n=5, 56%), involving relevant stakeholders (n=5, 56%), use of appropriate statistical techniques (n=5, 56%), following ethical requirements (n=4, 44%), and improving health care value (n=2, 22%). There were nine individual non-shared recommendations (3% of all recommendations) in five of the nine documents which did not fall in to one of the shared recommendation categories, including protection of the independence of peer review 5 , time and costs considerations as secondary objectives are defined 10 , and separation of feasibility studies from the main study results.
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Discussion
This study provides a synthesis of CER methods guidance documents for the purpose of informing decisions on the development and conduct of quality CER research. This consensus document identifies the most commonly shared expectations of quality CER from an interdisciplinary standpoint, incorporating recommendations from experts in academia, industry, professional societies, and regulatory agencies. Our study identified nine documents with over 300 recommendations for designing and conducting CER. We were able to identify the most frequently shared recommendations which can serve as a summary resource for researchers as they design and implement CER studies.
The documents had varying approaches to recommending specific CER Furthermore, transparency in statistical analysis is stressed in CER, allowing for not only public critique of methodology, but also study reproducibility.
The synthesis of these nine documents demonstrated a large degree of overlap, as over 97% of individual recommendations were found in at least two documents.
Though the documents themselves were not specifically reviewed for contradictions, no contradictions were noted in the extracted recommendations. Additionally, while individual documents may have primary areas of focus for conducting CER, the high degree of overlap suggests a general sense of agreement among the nine documents regarding the most important topics. Though a number of these topics are not exclusive to CER, and may be applied more broadly to pharmacoepidemiology and outcomes research, the emphasis placed on these recommendations by CER experts highlights their importance for CER, particularly when considering how CER contributes to clinical decision-making. 13 It should be noted that our consensus guide, summarizing key CER methods recommendations, may be useful in the development of detailed, high-quality, transparent CER that optimizes clinical applicability but does not replace the guidance provided by the individual documents identified. While the concept of consensus as a scientific theory has been controversial in the past, our goal was to present a summary of the overlap between the 312 recommendations from the nine CER methods guidance documents. 14 For specific guidance and additional CER resources, the reader is directed to the individual documents. Now that a consensus of recommendations has been identified, it will be important to identify whether consensus exists for how these recommendations should be implemented and accomplished.
While some recommendations extracted from the guides focus on the reporting of CER studies, they were interpreted as recommendations for the design and conduct for CER. For example, while reporting of limitations and confounders is not necessarily part of conducting research activities, it is an important step in promoting study transparency. With consistent transparency throughout the study process, study quality is improved. Furthermore, in the context of design, confounders and limitations should be considered a priori, so that approaches to minimize confounding and limitations can be implemented in the design phase. 4, 5 One such strategy includes sensitivity analyses, as "residual confounding should be assessed, and approaches to estimating its effect, including sensitivity analyses, should be included." 4, 15 The utility of sensitivity analyses is also supported by a recent study which identified sensitivity analyses as the single best predictor of quality for studies published in higher-impact journals. 16 The effect of missing data as a potential limitation must also be assessed thoroughly. 4, 15, 17 The goal of this project was to identify areas of agreement among CER methods recommendations to assist in the design and conduct of high-quality CER. Many of the recommendations were focused specifically on observational research, rather than RCT reporting in order to assess study validity. [20] [21] [22] While the aforementioned documents
were not included in our analysis as they were either not specific to CER or focused on reporting rather than the design and conduct of CER, they are important resources, particularly for the reporting of and assessment of CER quality. Lastly, it is also necessary to acknowledge international efforts to improve the utilization of effectiveness research methods in clinical decision-making, including the GetReal project conducted by the Innovative Medicines Initiative (IMI) and the European Medicines Agency's (EMA)
Draft guidance for Post-Authorization Efficacy Studies (PAES). 23, 24 There were several limitations in the development of our consensus document.
Firstly, selection of the documents utilized in our study was based upon specific search criteria. Thus, while our search returned an expansive list of articles for review, those documents that did not show up based on our search terminology were not included, such as the Guidelines for Good Pharmacoepidemiology Practices. 25 We used specific and reproducible criteria for searching the published literature, however, most of the guidance documents were identified from the grey literature search. Second, it should be noted that the documents reviewed for consensus were the most up-to-date revisions at the time the literature search was conducted. As such, guidance documents regularly updated may have more recent versions, including the ENCePP Guide on Methodological Standards in Pharmacoepidemiology (Revision 4). 26 Lastly, the extraction and categorization of shared recommendations was subject to the interpretation of two independent reviewers. In cases of disagreement regarding the extraction or categorization of specific recommendations within a shared recommendation category, a third independent reviewer was used for the final determination. We also mitigated this limitation by having all authors review and approve the categorization of all recommendations.
Conclusion
We conducted a systematic literature review to develop a single guide of recommended CER methods, and identified nine CER methods guidance documents.
The shared recommendations identified from this literature review emphasized adequate and transparent CER study planning and development using validated data, appropriate exposure measures, clinically meaningful and objectively measured outcomes, and statistical techniques which minimize bias and confounding. Further, CER should focus on areas that are relevant for decision-makers and adapt the interpretation and dissemination of results for key stakeholders. This overview of synthesized guidance may aid researchers and decision-makers in conducting and implementing quality comparative effectiveness research. 
